Cargando…
Quantitative detection of 4-hydroxyequilenin–DNA adducts in mammalian cells using an immunoassay with a novel monoclonal antibody
Estrogen–DNA adducts are potential biomarkers for assessing the risk and development of estrogen-associated cancers. 4-Hydroxyequilenin (4-OHEN) and 4-hydroxyequilin (4-OHEQ), the metabolites of equine estrogens present in common hormone replacement therapy (HRT) formulations, are capable of produci...
Autores principales: | Okahashi, Yumiko, Iwamoto, Takaaki, Suzuki, Naomi, Shibutani, Shinya, Sugiura, Shigeki, Itoh, Shinji, Nishiwaki, Tomohisa, Ueno, Satoshi, Mori, Toshio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896538/ https://www.ncbi.nlm.nih.gov/pubmed/20406772 http://dx.doi.org/10.1093/nar/gkq233 |
Ejemplares similares
-
Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei
por: Liedert, Bernd, et al.
Publicado: (2006) -
Determination of 2-acetylaminofluorene adducts by immunoassay
por: Poirier, Miriam C., et al.
Publicado: (1983) -
Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008) -
Ultrasensitive isolation, identification and quantification of DNA–protein adducts by ELISA-based RADAR assay
por: Kiianitsa, Kostantin, et al.
Publicado: (2014) -
Chemical discrimination between dC and (5Me)dC via their hydroxylamine adducts
por: Münzel, Martin, et al.
Publicado: (2010)